FACT SHEET: Clinical Trial
Providing clinical trial communications support ever since the original thrombolytic mega-study GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico) in 1987, MCS has extensive experience creating and executing innovative public relations programs that:
- Accelerate trial enrollment
- Increase product awareness within the marketplace
- Manage FDA review and approval communications
- Strengthen relationships with investigators and their sites
Patient Recruitment
MCS develops targeted patient recruitment initiatives for studies in a variety of therapeutic areas, including oncology, cardiology, rheumatology and infectious diseases. Our patient recruitment team is adept at adhering to strict regulatory guidelines and IRB requirements, while fostering partnerships with key investigators and sites. Recruitment programs that we have developed include:
- Breast Cancer International Research Group (BCIRG): Generated media coverage in local markets of U.S. sites for two of the largest global clinical trials (BCIRG-005 and BCIRG-006) of adjuvant therapy for breast cancer.
- Genentech, Inc.: Augmented hospital site recruitment efforts for 1,500-patient COOL (Cardiovascular thrombolytic to Open Occluded Lines) trials and increased patient referrals by targeting diverse professional specialties.
- Immunex: Implemented a targeted, customized recruitment campaign for rheumatoid arthritis patients for study of Enbrel®, completing enrollment ahead of expected timeline. Public relations audience reach exceeded 28 million nationwide, including 17 million in site areas.
- ViroPharma: Supported client initiatives to recruit pediatric and adult patients with viral meningitis for study of pleconaril.
Developing Relationships with the Experts
Clinical trials are opportunities to develop relationships with participating investigators and institutions through ongoing contact and support. During the trial and the regulatory review process, MCS works closely with investigators, institutions and our clients to ensure that everyone stays abreast of trial progress, maintains interest in study goals and is involved in external communications activities. We often conduct local publicity campaigns in support of key opinion leaders and study sites.
Data Support
MCS specializes in translating complex clinical data into meaningful messages that resonate with physicians and consumers. We develop core press materials, media train spokespeople and collaborate with leading research institutions to support data announcements at major medical meetings, such as the American College of Cardiology, the American Society of Clinical Oncology, and the American College of Rheumatology.
Results
When it comes to showcasing the publication of data, MCS has placed news in influential consumer media outlets, including USA Today, The Wall Street Journal, The New York Times, CNN Headline News, ABC World News Tonight, NBC Nightly News and CBS Evening News, while working within the embargo policies of the premiere medical journals, including The New England Journal of Medicine, The Journal of the American Medical Association, Lancet, and Journal of Clinical Oncology.
